Haemonetics Corporation (HAZ)
XDUS
Closed
Oct 8, 2026
Day's Range
89.0052 wk Range
40.80Overview - HAZ - Haemonetics Corporation
Key Statistics
Valuation
Enterprise Value
979.14M
P/E (Trailing)
‪45.09‬
PEG Ratio
‪15.65‬
Price / Book
‪5.03‬
EV / EBITDA
‪2.77‬
Profitability
Gross Margin
‪59.75%‬
Profit Margin
‪59.03%‬
Operating Margin
‪11.74%‬
Return on Assets
‪4.06%‬
Return on Equity
‪12.21%‬
Ownership
Shares Outstanding
45.47M
Price stats
50-Day Avg
‪81.16‬
200-Day Avg
‪62.72‬
Peers - HAZ - Haemonetics Corporation
Peer Comparison
Compared with companies in Medical Devices listed on XDUS.
- HAZXDUSHaemonetics Corporation+56.56%52-week change45.09P/E (Trailing)‪59.03%‬Profit Margin
- PENXDUSPBF Energy Inc. Class A Common Stock+57.10%52-week change-44.13P/E (Trailing)‪-1.94%‬Profit Margin
- NG2XDUSNeogen Corp.+53.44%52-week change-274.00P/E (Trailing)‪46.93%‬Profit Margin
- 6GJXDUSGlaukos Corp.+48.88%52-week change-40.85P/E (Trailing)‪55.72%‬Profit Margin
- BKDXDUSBruker Corp.+44.96%52-week change-373.20P/E (Trailing)‪45.91%‬Profit Margin
- MEDXDUSMediClin AG+44.67%52-week change9.91P/E (Trailing)‪84.38%‬Profit Margin
- 0M61XDUSMyomo Inc.+44.06%52-week change-3.69P/E (Trailing)‪65.69%‬Profit Margin
Profile Summary - HAZ - Haemonetics Corporation
About
Haemonetics Corporation is a medical technology company that develops products and services for blood and plasma collection, hospital transfusion management, and selected interventional procedures. Its Plasma segment provides automated collection systems, donor management software, and related disposables that support…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
